Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Migraine With Aura, Migraine Without Aura
About this trial
This is an interventional prevention trial for Migraine With Aura focused on measuring Migraine, Migraine prophylaxis
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of migraine with or without aura (typical aura with migraine headache) Subjects who had an average of two or more migraine frequencies per month during the 3 months before screening Exclusion Criteria: Female subjects who are pregnant, lactating Chronic daily headache Previous treatment with three or more migraine prophylaxis medications failed Subjects with hepatic disease whose liver enzymes are over 2 times of upper limit of reference or significant dysfunction Coexisting medical, neurological, or psychiatric disorder that may hinder the study according to the investigator's judgment
Sites / Locations
- Changhua Christian Hospital
- Chung-Ho Memorial Hospital, Kaohsiung Medical University
- Chang-Gung Memorial Hospital
- Chinese Medical University Hospital
- SinLau Christian Hospital
- Taipei Veterans General Hospital
- Taipei Medical University Hospital